The £115m price tag had seemed to hang around his neck like a glittering weight in his early days at Chelsea but we're now ...

Leicester's stunning title win remains one of the great underdog stories in sports. What do the players who made it happen think of their achievement today? And will we ever see a team match their ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...

Experts recommend eating foods high in probiotics before taking a supplement for weight loss, but supplements can help fill ...

After hitting a record high, the U.S. rate of obesity is falling, as the number of people taking GLP-1 medications rises ...

Gallup’s latest health index links the rapid rise of semaglutide and similar injectables to measurable population-level weight loss.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do side ...